Aytu Biopharma (AYTU) FCF Margin Growth (5y) (2019 - 2025)
Aytu Biopharma (AYTU) FCF Margin Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,331.00 |
| Sep 30, 2025 | 5,472.00 |
| Jun 30, 2025 | 3,147.00 |
| Mar 31, 2025 | -27,137.00 |
| Dec 31, 2024 | 35,171.00 |
| Sep 30, 2024 | 19,951.00 |
| Jun 30, 2024 | 22,047.00 |
| Mar 31, 2024 | 10,628.00 |
| Dec 31, 2023 | 28,321.00 |
| Sep 30, 2023 | 19,092.00 |
| Jun 30, 2023 | 52,160.00 |
| Mar 31, 2023 | 66,882.00 |
| Dec 31, 2022 | 28,554.00 |
| Sep 30, 2022 | 35,895.00 |
| Jun 30, 2022 | 36,522.00 |
| Mar 31, 2022 | 30,896.00 |
| Dec 31, 2021 | 26,170.00 |
| Sep 30, 2021 | 81,827.00 |
| Jun 30, 2021 | 40,233.00 |
| Dec 31, 2020 | 83,114.00 |